﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Mon, 20 Apr 2026 08:22:18 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/February-2022/rss/3147</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/February-2022/rss/3147" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New and Approved]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-46</link><description><![CDATA[  APhA Staff  

   New Formulations   

 CABOTEGRAVIR 
(Apretude—ViiV Healthcare) 

  Drug class:  HIV-1 integrase strand transfer inhibitor (INSTI). 

  Indication:  Apretude is indicated ...]]></description><pubDate>Fri, 07 Jan 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-46</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3157]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[ApoB could be best predictor of future MI risk]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/apob-could-be-best-predictor-of-future-mi-risk</link><description><![CDATA[  Maria G. Tanzi, PharmD  

   

 Apoprotein B (ApoB) was the only lipid parameter significantly associated with an increased risk of myocardial infarction (MI), according to results of a ...]]></description><pubDate>Fri, 07 Jan 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/apob-could-be-best-predictor-of-future-mi-risk</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3151]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Think twice about using Google Translate for patient counseling and medication directions]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/think-twice-about-using-google-translate-for-patient-counseling-and-medication-directions</link><description><![CDATA[  Loren Bonner  

   

 Results of a new study about Google Translate for patient medication directions and counseling points should be taken as a warning for pharmacists. 

 The study, ...]]></description><pubDate>Fri, 07 Jan 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/think-twice-about-using-google-translate-for-patient-counseling-and-medication-directions</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3152]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[At-home COVID-19 diagnostic tests: Answering important questions]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/at-home-covid-19-diagnostic-tests-answering-important-questions</link><description><![CDATA[  Clarissa Chan, PharmD  

   

 Home-based rapid diagnostic testing is integral in the fight against COVID-19. 

 “Home tests can be an important tool for preventing the spread of COVID-19 and ...]]></description><pubDate>Fri, 07 Jan 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/at-home-covid-19-diagnostic-tests-answering-important-questions</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3153]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Here’s what we know about FDA-authorized COVID-19 antivirals]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/heres-what-we-know-about-fda-authorized-covid-19-antivirals</link><description><![CDATA[  Loren Bonner  

   

 While FDA has authorized two COVID-19 antiviral medications—Paxlovid from Pfizer and molnupiravir from Merck, Americans may not have the easiest time accessing these ...]]></description><pubDate>Fri, 07 Jan 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/heres-what-we-know-about-fda-authorized-covid-19-antivirals</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3154]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Many oral disorders lend themselves to self care]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/many-oral-disorders-lend-themselves-to-self-care</link><description><![CDATA[  Daniel L. Krinsky, BS, MS, RPh, FAPhA  

   

 Whether it’s to help a parent looking for a product for their teething infant or a college-aged student interested in options to manage cold ...]]></description><pubDate>Fri, 07 Jan 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/many-oral-disorders-lend-themselves-to-self-care</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3155]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Can immune-boosting supplements help support patients with COVID-19?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/can-immune-boosting-supplements-help-support-patients-with-covid-19</link><description><![CDATA[  Johanna Taylor Katroscik, PharmD  

   

 Although supplement sales have skyrocketed since the beginning of the pandemic, there is no scientific evidence that immune-boosting supplements can ...]]></description><pubDate>Fri, 07 Jan 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/can-immune-boosting-supplements-help-support-patients-with-covid-19</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3156]]></dc:identifier></item></channel></rss>